First U.S. patient receives autologous stem cell therapy to treat dry AMD

First U.S. patient receives autologous stem cell therapy to treat dry AMD

Media Advisory Wednesday, August 31, 2022 What: At the National Institutes of Health, a surgical team successfully implanted a patch of tissue made from patient cells with the goal of treating advanced “dry” age-related macular degeneration (AMD), also known as geographic atrophy. Dry AMD is a leading cause of vision loss among older Americans and … Read more